Literature DB >> 10623626

Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.

E T Zumpe1, N Tilakaratne, N J Fraser, G Christopoulos, S M Foord, P M Sexton.   

Abstract

Calcitonin (CT), calcitonin gene-related peptide (CGRP), amylin, and adrenomedullin constitute a family of structurally related peptides that signal via either the calcitonin receptor-like receptor or the CT receptor, with receptor phenotype determined by coexpression of one of the three receptor activity-modifying proteins (RAMPs). The nature of the interaction between the receptor and RAMP was investigated using chimeras between RAMP1 and RAMP2 where the amino-terminal domain of RAMP1 was attached to the transmembrane domain and carboxy terminus of RAMP2 and called RAMP1/2, and vice versa for RAMP2/1. Cotransfection of wild-type or chimeric RAMPs with the insert-negative isoform of the human CT receptor (hCTR(I1-)) into COS-7 cells resulted in the expression of (125)I-rat amylin binding sites. Highest specific binding was observed when either RAMP1 or RAMP2/1 were cotransfected, indicating the importance of the RAMP transmembrane domain and/or carboxy terminus for the degree to which amylin receptors are expressed. In contrast, the phenotype generated was primarily determined by the amino terminus, with similar RAMP1- and RAMP1/2-induced receptor phenotypes that had higher affinity for human CGRPalpha and lower affinity for human calcitonin than the RAMP2- and RAMP2/1-induced receptors. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623626     DOI: 10.1006/bbrc.1999.1943

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.

Authors:  John Simms; Debbie L Hay; Mark Wheatley; David R Poyner
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

2.  Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.

Authors:  L Edvinsson; E Nilsson; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

Review 3.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

Review 4.  Structure-function relationships of the N-terminus of receptor activity-modifying proteins.

Authors:  Tao Qi; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

5.  The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc).

Authors:  Lynda Whiting; James E McCutcheon; Christina N Boyle; Mitchell F Roitman; Thomas A Lutz
Journal:  Physiol Behav       Date:  2017-03-22

6.  Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Authors:  Sang-Min Lee; Debbie L Hay; Augen A Pioszak
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

Review 7.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

8.  Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; John Simms; George Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

Review 9.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

10.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.